Coronaviruses and Toroviruses

Principles and Practice of Clinical Virology: Sixth Edition

Volumn , Issue , 2009, Pages 511-531

  Peiris, J S Malik ^a   Poon, L L M ^b  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b HKU PASTEUR RESEARCH CENTRE   (Hong Kong)

Author keywords

Bovine torovirus (BToV); Coronaviruses and toroviruses human enteric tract; Coronaviruses and toroviruses pleomorphic; Human torovirus (HTV); Infectious bronchitis virus (IBV); Prophylaxis: active and passive immunization

Indexed keywords

EID: 84879843085     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470741405.ch21     Document Type: Chapter

References (138)

1. Afzelius, B.A. (1994) Ultrastructure of human nasal epithelium during an episode of coronavirus infection. Virchows Archiv, 424, 295-300.
2. Arbour, N., Day, R., Newcombe, J. and Talbot, P.J. (2000) Neuroinvasion by human respiratory coronaviruses. Journal of Virology, 74, 8913-21.
3. Arden, K.E., Nissen, M.D., Sloots, T.P. and Mackay, I.M. (2005) New human coronavirus, HCoV-NL63, associated with severe lower respiratory tract disease in Australia. Journal of Medical Virology, 75, 455-62.
4. Atmar, R.L., Guy, E., Guntupalli, K.K. et al. (1998) Respiratory tract viral infections in inner-city asthmatic adults. Archives of Internal Medicine, 158, 2453-59.
5. Ballesteros, M.L., Sanchez, C.M. and Enjuanes, L. (1997) Two amino acid changes at the N-terminus of transmissible gastroenteritis coronavirus spike protein result in the loss of enteric tropism. Virology, 227, 378-88.
6. Barnard, D.L., Day, C.W., Bailey, K. et al. (2006a) Evaluation of immunomodulators, interferons and known in vitro SARS-coV inhibitors for inhibition of SARS-coV replication in BALB/c mice. Antiviral Chemistry and Chemotherapy, 17, 275-84.
7. Barnard, D.L., Day, C.W., Bailey, K. et al. (2006b) Enhancement of the infectivity of SARS-CoV in BALB/c mice by IMP dehydrogenase inhibitors, including ribavirin. Antiviral Research, 71, 53-63.
8. Beards, G.M., Hall, C., Green, J. et al. (1984) An enveloped virus in stools of children and adults with gastroenteritis that resembles the Breda virus of calves. Lancet, 1, 1050-52.
9. Beaudette, F.R. and Hudson, C.B. (1937) Cultivation of the virus of infectious bronchitis. Journal of the American Veterinary Medical Association, 90, 51-60.
10. van Benten, I.J., KleinJan, A., Neijens, H.J. et al. (2001) Prolonged nasal eosinophilia in allergic patients after common cold. Allergy, 56, 949-56.
11. Boivin, G., Baz, M., Cote, S. et al. (2005) Infections by human coronavirus-NL in hospitalized children. The Pediatric Infectious Disease Journal, 24, 1045-48.
12. Bradburne, A.F., Bynoe, M.L. and Tyrrell, D.A. (1967) Effects of a 'new' human respiratory virus in volunteers. British Medical Journal, 3, 767-69.
13. Buchholz, U.J., Bukreyev, A., Yang, L. et al. (2004) Contributions of the structural proteins of severe acute respiratory syndrome coronavirus to protective immunity. Proceedings of the National Academy of Sciences of the United States of America, 101, 9804-809.
14. Cao, W.C., Liu, W., Zhang, P.H. et al. (2007) Disappearance of antibodies to SARS-associated coronavirus after recovery. The New England Journal of Medicine, 357, 1162-63.
15. Cavanagh, D. and Naqi, S. (2003) Infectious bronchitis, in Diseases of Poultry, 11th edn (eds Y.M. Saif, H.J. Barnes J.R. Glisson et al.), Iowa State Press, Iowa, pp. 101-19.
16. Chan, K.H., Poon, L.L., Cheng, V.C. et al. (2004) Detection of SARS coronavirus in patients with suspected SARS. Emerging Infectious Diseases, 10, 294-99.
17. Chan, K.H., Cheng, V.C.,Woo, P.C. et al. (2005) Serological responses in patients with severe acute respiratory syndrome coronavirus infection and cross-reactivity with human coronaviruses 229E, OC43, and NL63. Clinical and Diagnostic Laboratory Immunology, 12, 1317-21.
18. Cheng, V.C., Lau, S.K., Woo, P.C. and Yuen, K.Y. (2007) Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection. Clinical Microbiology Reviews, 20, 660-94.
19. Cheng, Y., Wong, R., Soo, Y.O. et al. (2005) Use of convalescent plasma therapy in SARS patients in Hong Kong. European Journal of Clinical Microbiology and Infectious Diseases, 24, 44-46.
20. Cheung, C.Y., Poon, L.L., Ng, I.H. et al. (2005) Cytokine responses in severe acute respiratory syndrome coronavirus-infected macrophages in vitro: possible relevance to pathogenesis. Journal of Virology, 79, 7819-26.
21. Chiu, S.S., Chan, K.H., Chu, K.W. et al. (2005) Human coronavirus NL63 infection and other coronavirus infections in children hospitalized with acute respiratory disease in Hong Kong, China. Clinical Infectious Diseases, 40, 1721-29.
22. Chow, K.Y., Lee, C.E., Ling, M.L. et al. (2004) Outbreak of severe acute respiratory syndrome in a tertiary hospital in Singapore, linked to an index patient with atypical presentation: epidemiological study. BritishMedical Journal, 328, 195.
23. Chu, C.M., Cheng, V.C., Hung, I.F. et al. (2004a) Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings. Thorax, 59, 252-56.
24. Chu, C.M., Poon, L.L., Cheng, V.C. et al. (2004b) Initial viral load and the outcomes of SARS. Canadian Medical Association Journal, 171, 1349-52.
25. Cornelissen, L.A., Wierda, C.M., van derMeer, F.J. et al. (1997) Hemagglutinin-esterase, a novel structural protein of torovirus. Journal of Virology, 71, 5277-86.
26. Cornelissen, L.A., van Woensel, P.A., de Groot, R.J. et al. (1998) Cell culture-grown putative bovine respiratory torovirus identified as a coronavirus. The Veterinary Record, 142, 683-86.
27. Dare, R.K., Fry, A.M., Chittaganpitch, M. et al. (2007) Human coronavirus infections in rural Thailand: a comprehensive study using real-time reverse-transcription polymerase chain reaction assays. The Journal of Infectious Diseases, 196, 1321-28.
28. Drosten, C., Gunther, S., Preiser, W. et al. (2003) Identification of a novel coronavirus in patients with severe acute respiratory syndrome. The New England Journal of Medicine, 348, 1967-76.
29. Duckmanton, L., Luan, B., Devenish, J. et al. (1997) Characterization of torovirus from human fecal specimens. Virology, 239, 158-68.
30. van Elden, L.J., van Loon, A.M., van Alphen, F. et al. (2004) Frequent detection of human coronaviruses in clinical specimens from patients with respiratory tract infection by use of a novel real-time reverse-transcriptase polymerase chain reaction. The Journal of Infectious Diseases, 189, 652-57.
31. Enjuanes, L., Brian, D., Cavanagh, D. et al. (2000) Coronaviridae, in Virus Taxonomy (eds M.H.V. Rengenmortel, C.M. Fauquet, D.H.L. Bishop et al.), Academic Press New York, pp. 835-49.
32. Esper, F., Weibel, C., Ferguson, D. et al. (2005) Evidence of a novel human coronavirus that is associated with respiratory tract disease in infants and young children. The Journal of Infectious Diseases, 191, 492-98.
33. Falsey, A.R., Walsh, E.E. and Hayden, F.G. (2002) Rhinovirus and coronavirus infection-associated hospitalizations among older adults. The Journal of Infectious Diseases, 185, 1338-41.
34. Farcas, G.A., Poutanen, S.M., Mazzulli, T. et al. (2005) Fatal severe acute respiratory syndrome is associated with multiorgan involvement by coronavirus. The Journal of Infectious Diseases, 191, 193-97.
35. Fouchier, R.A., Kuiken, T., Schutten, M. et al. (2003) Aetiology: Koch's postulates fulfilled for SARS virus. Nature, 423, 240.
36. Franks, T.J., Chong, P.Y., Chui, P. et al. (2003) Lung pathology of severe acute respiratory syndrome (SARS): A study of 8 autopsy cases from Singapore. Human Pathology, 34, 729.
37. Freymuth, F., Vabret, A., Brouard, J. et al. (1999) Detection of viral, Chlamydia pneumoniae and Mycoplasma pneumoniae infections in exacerbations of asthma in children. Journal of Clinical Virology, 13, 131-39.
38. van Gageldonk-Lafeber, A.B., Heijnen, M.L., Bartelds, A.I. et al. (2005) A case-control study of acute respiratory tract infection in general practice patients in The Netherlands. Clinical Infectious Diseases, 41, 490-97.
39. Gallagher, T.M. and Buchmeier, M.J. (2001) Coronavirus spike proteins in viral entry and pathogenesis. Virology, 279, 371-4.
40. Garbino, J., Crespo, S., Aubert, J.D. et al. (2006) A prospective hospital-based study of the clinical impact of non-severe acute respiratory syndrome (non-SARS)-related human coronavirus infection. Clinical Infectious Diseases, 43, 1009-15.
41. Gillim-Ross, L. and Subbarao, K. (2006) Emerging respiratory viruses: challenges and vaccine strategies. Clinical Microbiology Reviews, 19, 614-36.
42. Gonzalez, J.M., Gomez-Puertas, P., Cavanagh, D. et al. (2003) A comparative sequence analysis to revise the current taxonomy of the family Coronaviridae. Archives of Virology, 148, 2207-35.
43. Gorbalenya, A.E., Enjuanes, L., Ziebuhr, J. and Snijder, E.J. (2006) Nidovirales: evolving the largest RNA virus genome. Virus Research, 117, 17-37.
44. Graat, J.M., Schouten, E.G., Heijnen, M.L. et al. (2003) A prospective, community-based study on virologic assessment among elderly people with and without symptoms of acute respiratory infection. Journal of Clinical Epidemiology, 56, 1218-23.
45. de Groot, R.J. and Horzinek, M.C. (1995) Feline infectious peritonitis, in The Coronaviridae (ed. S.J. Siddell), Plenum Press, New York, pp. 293-315.
46. Guan, Y., Zheng, B.J., He, Y.Q. et al. (2003) Isolation and characterization of viruses related to the SARS coronavirus from animals in Southern China. Science, 302, 276-78.
47. Haagmans, B.L. and Osterhaus, A.D. (2006) Coronaviruses and their therapy. Antiviral Research, 71, 397-403.
48. Haagmans, B.L., Kuiken, T., Martina, B.E. et al. (2004) Pegylated interferon-alpha protects type 1 pneumocytes against SARS coronavirus infection in macaques. Nature Medicine, 10, 290-93.
49. Hamre, D. and Beem, M. (1972) Virologic studies of acute respiratory disease in young adults. V. Coronavirus 229E infections during six years of surveillance. American Journal of Epidemiology, 96, 94-106.
50. Hamre, D. and Procknow, J.J. (1966) A new virus isolated from the human respiratory tract. Proceedings of the Society for Experimental Biology and Medicine, 121, 190-93.
51. de Haan, C.A., Volders, H., Koetzner, C.A. et al. (2002) Coronaviruses maintain viability despite dramatic rearrangements of the strictly conserved genome organization. Journal of Virology, 76, 12491-502.
52. van der Hoek, L. (2007) Human coronaviruses: what do they cause? Antiviral Therapy, 12, 651-58.
53. van der Hoek, L., Pyrc, K., Jebbink, M.F. et al. (2004) Identification of a new human coronavirus. Nature Medicine, 10, 368-73.
54. van der Hoek, L., Sure, K., Ihorst, G. et al. (2005) Croup is associated with the novel coronavirus NL63. PLoS Medicine, 2, e240.
55. Hofmann, H., Pyrc, K., van der Hoek, L. et al. (2005) Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry. Proceedings of the National Academy of Sciences of the United States of America, 102, 7988-93.
56. Ip, W.K., Chan, K.H., Law, H.K. et al. (2005) Mannose-binding lectin in severe acute respiratory syndrome coronavirus infection. The Journal of Infectious Diseases, 191, 1697-704.
57. Jamieson, F.B., Wang, E.E., Bain, C. et al. (1998) Human torovirus: a new nosocomial gastrointestinal pathogen. The Journal of Infectious Diseases, 178, 1263-69.
58. Kam, Y.W., Kien, F., Roberts, A. et al. (2007) Antibodies against trimeric S glycoprotein protect hamsters against SARS-CoV challenge despite their capacity to mediate FcgammaRII-dependent entry into B cells in vitro. Vaccine, 25, 729-40.
59. Kistler, A., Avila, P.C., Rouskin, S. et al. (2007) Pan-viral screening of respiratory tract infections in adults with and without asthma reveals unexpected human coronavirus and human rhinovirus diversity. The Journal of Infectious Diseases, 196, 817-25.
60. Koopmans, M.P., Goosen, E.S., Lima, A.A. et al. (1997) Association of torovirus with acute and persistent diarrhea in children. The Pediatric Infectious Disease Journal, 16, 504-7.
61. Ksiazek, T.G., Erdman, D., Goldsmith, C.S. et al. (2003) A novel coronavirus associated with severe acute respiratory syndrome. The New England Journal of Medicine, 348, 1953-66.
62. Lai, M.M. and Cavanagh, D. (1997) The molecular biology of coronaviruses. Advances in Virus Research, 48, 1-100.
63. Lau, S.K., Woo, P.C., Li, K.S. et al. (2005) Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats. Proceedings of the National Academy of Sciences of the United States of America, 102, 14040-45.
64. Lau, S.K., Woo, P.C., Yip, C.C. et al. (2006) Coronavirus HKU1 and other coronavirus infections in Hong Kong. Journal of Clinical Microbiology, 44, 2063-71.
65. Lee, N., Allen Chan, K.C., Hui, D.S. et al. (2004) Effects of early corticosteroid treatment on plasma SARS-associated Coronavirus RNA concentrations in adult patients. Journal of Clinical Virology, 31, 304-309.
66. Leung, W.K., To, K.F., Chan, P.K. et al. (2003) Enteric involvement of severe acute respiratory syndrome-associated coronavirus infection. Gastroenterology, 125, 1011-17.
67. Leung, C.W., Kwan, Y.W., Ko, P.W. et al. (2004a) Severe acute respiratory syndrome among children. Pediatrics, 113, e535-e543.
68. Leung, G.M., Chung, P.H., Tsang, T. et al. (2004b) SARS-CoV antibody prevalence in all Hong Kong patient contacts. Emerging Infectious Diseases, 10, 1653-56.
69. Li, W., Shi, Z., Yu, M. et al. (2005a) Bats are natural reservoirs of SARS-like coronaviruses. Science, 310, 676-79.
70. Li, W., Zhang, C., Sui, J. et al. (2005b) Receptor and viral determinants of SARS-coronavirus adaptation to human ACE2. The EMBO Journal, 24, 1634-43.
71. Liang, G., Chen, Q., Xu, J. et al. (2004) Laboratory diagnosis of four recent sporadic cases of community-acquired SARS, Guangdong Province, China. Emerging Infectious Diseases, 10, 1774-81.
72. Lipsitch, M., Cohen, T., Cooper, B. et al. (2003) Transmission dynamics and control of severe acute respiratory syndrome. Science, 300, 1966-70.
73. Loutfy, M.R., Blatt, L.M., Siminovitch, K.A. et al. (2003) Interferon alfacon-1 plus corticosteroids in severe acute respiratory syndrome: a preliminary study. JAMA: The Journal of the American Medical Association, 290, 3222-28.
74. McIntosh, K., Kapikian, A.Z., Turner, H.C. et al. (1970) Seroepidemiologic studies of coronavirus infection in adults and children. American Journal of Epidemiology, 91, 585-92.
75. McIntosh, K., Ellis, E.F., Hoffman, L.S. et al. (1973) The association of viral and bacterial respiratory infections with exacerbations of wheezing in young asthmatic children. The Journal of Pediatrics, 82, 578-90.
76. McKean, M.C., Leech, M., Lambert, P.C. et al. (2001) A model of viral wheeze in nonasthmatic adults: symptoms and physiology. The European Respiratory Journal, 18, 23-32.
77. Makela, M.J., Puhakka, T., Ruuskanen, O. et al. (1998) Viruses and bacteria in the etiology of the common cold. Journal of Clinical Microbiology, 36, 539-42.
78. Masters, P.S. (2006) The molecular biology of coronaviruses. Advances in Virus Research, 66, 193-292.
79. ter Meulen, J., Bakker, A.B., van den Brink, E.N. et al. (2004) Human monoclonal antibody as prophylaxis for SARS coronavirus infection in ferrets. Lancet, 363, 2139-41.
80. Morgenstern, B., Michaelis, M., Baer, P.C. et al. (2005) Ribavirin and interferon-beta synergistically inhibit SARS-associated coronavirus replication in animal and human cell lines. Biochemical and Biophysical Research Communications, 326, 905-8.
81. Mossel, E.C., Wang, J., Jeffers, S. et al. (2007) SARS-CoV replicates in primary human alveolar type II cell cultures but not in type I-like cells. Virology, 369, 288-98.
82. Myint, S. (1995) Human coronavirus infections, in The Coronaviridae (ed. S.G. Siddell), Plenum Press, New York, pp. 389-401.
83. Ng, E.K., Hui, D.S., Chan, K.C. et al. (2003) Quantitative analysis and prognostic implication of SARS coronavirus RNA in the plasma and serum of patients with severe acute respiratory syndrome. Clinical Chemistry, 49, 1976-80.
84. Nicholls, J.M., Poon, L.L., Lee, K.C. et al. (2003) Lung pathology of fatal severe acute respiratory syndrome. Lancet, 361, 1773-78.
85. Nicholls, J.M., Butany, J., Poon, L.L. et al. (2006) Time course and cellular localization of SARS-CoV nucleoprotein and RNA in lungs from fatal cases of SARS. PLoS Medicine, 3, e27.
86. Olsen, C.W. (1993) A review of feline infectious peritonitis virus: molecular biology, immunopathogenesis, clinical aspects, and vaccination. Veterinary Microbiology, 36, 1-37.
87. Peiris, J.S., Chu, C.M., Cheng, V.C. et al. (2003a) Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet, 361, 1767-72.
88. Peiris, J.S., Lai, S.T., Poon, L.L. et al. (2003b) Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet, 361, 1319-25.
89. Peiris, J.S., Yuen, K.Y., Osterhaus, A.D. and Stohr, K. (2003c) The severe acute respiratory syndrome. The New England Journal of Medicine, 349, 2431-41.
90. Peiris, J.S.M., Guan, Y. and Poon, L.L.M. (2007) Severe acute respiratory syndrome (SARS), in Emerging Infections 7 (eds W.M. Scheld, D.C. Hooper and J.M. Huges), ASM Press, Washington, DC, pp. 23-50.
91. Pitkaranta, A., Virolainen, A., Jero, J. et al. (1998) Detection of rhinovirus, respiratory syncytial virus, and coronavirus infections in acute otitis media by reverse transcriptase polymerase chain reaction. Pediatrics, 102, 291-95.
92. Poon, L.L., Chu, D.K., Chan, K.H. et al. (2005a) Identification of a novel coronavirus in bats. Journal of Virology, 79, 2001-9.
93. Poon, L.L., Leung, C.S., Chan, K.H. et al. (2005b) Recurrent mutations associated with isolation and passage of SARS coronavirus in cells from non-human primates. Journal of Medical Virology, 76, 435-40.
94. Popova, R. and Zhang, X. (2002) The spike but not the hemagglutinin/esterase protein of bovine coronavirus is necessary and sufficient for viral infection. Virology, 294, 222-36.
95. Quan, P.L., Palacios, G., Jabado, O.J. et al. (2007) Detection of respiratory viruses and subtype identification of influenza A viruses by GreeneChipResp oligonucleotide microarray. Journal of Clinical Microbiology, 45, 2359-64.
96. Raamsman, M.J., Locker, J.K., de Hooge, A. et al. (2000) Characterization of the coronavirus mouse hepatitis virus strain A59 small membrane protein E. Journal of Virology, 74, 2333-42.
97. Rabenau, H.F., Cinatl, J., Morgenstern, B. et al. (2005) Stability and inactivation of SARS coronavirus. Medical Microbiology and Immunology, 194, 1-6.
98. Rao, P.V., Kumari, S. and Gallagher, T.M. (1997) Identification of a contiguous 6-residue determinant in the MHV receptor that controls the level of virion binding to cells. Virology, 229, 336-48.
99. Riley, S., Fraser, C., Donnelly, C.A. et al. (2003) Transmission dynamics of the etiological agent of SARS in Hong Kong: impact of public health interventions. Science, 300, 1961-66.
100. Rockx, B., Sheahan, T., Donaldson, E. et al. (2007) Synthetic reconstruction of zoonotic and early human severe acute respiratory syndrome coronavirus isolates that produce fatal disease in aged mice. Journal of Virology, 81, 7410-23.
101. Rockx, B., Corti, D., Donaldson, E. et al. (2008) Structural basis for potent cross-neutralizing human monoclonal antibody protection against lethal human and zoonotic SARS-CoV challenge. Journal of Virology, 82, 3220-35.
102. Saif, L. (2005) Comparative biology of animal coronaviruses: lessons for SARS, in Severe Acute Respiratory Syndrome (eds M. Peiris, L.J. Anderson, A.D.M.E. Osterhaus et al), Blackwell Publishing, Oxford, pp. 84-99.
103. Saif, L. (2006) Animal coronaviruses, in SARS: How a Global Epidemic was Stopped, World Health Organization, Geneva, pp. 199-209.
104. Salanueva, I.J., Carrascosa, J.L. and Risco, C. (1999) Structural maturation of the transmissible gastroenteritis coronavirus. Journal of Virology, 73, 7952-64.
105. Schickli, J.H., Zelus, B.D., Wentworth, D.E. et al. (1997) The murine coronavirus mouse hepatitis virus strain A59 from persistently infected murine cells exhibits an extended host range. Journal of Virology, 71, 9499-07.
106. Schultze, B. and Herrler, G. (1992) Bovine coronavirus uses N-acetyl-9-O-acetylneuraminic acid as a receptor determinant to initiate the infection of cultured cells. The Journal of General Virology, 73 (Pt 4), 901-6.
107. Seto, W.H., Tsang, D., Yung, R.W. et al. (2003) Effectiveness of precautions against droplets and contact in prevention of nosocomial transmission of severe acute respiratory syndrome (SARS). Lancet, 361, 1519-20.
108. Shao, X., Guo, X., Esper, F. et al. (2007) Seroepidemiology of group I human coronaviruses in children. Journal of Clinical Virology, 40, 207-13.
109. Siddell, S.G. (1995) The Coronaviridae: and introduction, in The Coronaviridae (ed. S.G. Siddell), Plenum Press, New York, pp. 1-10.
110. Sims, A.C., Baric, R.S., Yount, B. et al. (2005) Severe acute respiratory syndrome coronavirus infection of human ciliated airway epithelia: role of ciliated cells in viral spread in the conducting airways of the lungs. Journal of Virology, 79, 15511-24.
111. Sizun, J., Soupre, D., Giroux, J.D. and Legrand, M.C. (1995) Nosocomial respiratory infection due to coronavirus in neonatal intensive care units: prospective evaluation. Archives de Pediatrie, 2, 1020-21.
112. Sloots, T.P., McErlean, P., Speicher, D.J. et al. (2006) Evidence of human coronavirus HKU1 and human bocavirus in Australian children. Journal of Clinical Virology, 35, 99-102.
113. Sola, I., Moreno, J.L., Zuniga, S. et al. (2005) Role of nucleotides immediately flanking the transcription-regulating sequence core in coronavirus subgenomic mRNA synthesis. Journal of Virology, 79, 2506-16.
114. Stephensen, C.B., Casebolt, D.B. and Gangopadhyay, N.N. (1999) Phylogenetic analysis of a highly conserved region of the polymerase gene from 11 coronaviruses and development of a consensus polymerase chain reaction assay. Virus Research, 60, 181-89.
115. Stohlman, S.A. and Hinton, D.R. (2001) Viral induced demyelination. Brain Pathology, 11, 92-106.
116. Subbarao, K., McAuliffe, J., Vogel, L. et al. (2004) Prior infection and passive transfer of neutralizing antibody prevent replication of severe acute respiratory syndrome coronavirus in the respiratory tract of mice. Journal of Virology, 78, 3572-77.
117. Tan, E.L., Ooi, E.E., Lin, C.Y. et al. (2004) Inhibition of SARS coronavirus infection in vitro with clinically approved antiviral drugs. Emerging Infectious Diseases, 10, 581-86.
118. Tan, K., Zelus, B.D., Meijers, R. et al. (2002) Crystal structure of murine sCEACAM1a[1,4]: a coronavirus receptor in the CEA family. The EMBO Journal, 21, 2076-86.
119. Thiel, V., Ivanov, K.A., Putics, A. et al. (2003) Mechanisms and enzymes involved in SARS coronavirus genome expression. The Journal of General Virology, 84, 2305-15.
120. Tyrrell, D.A.J. and Bynoe, M.L. (1965) Cultivation of a novel type of common-cold virus in organ cultures. British Medical Journal, 1, 1467-70.
121. Vabret, A., Mouthon, F., Mourez, T. et al. (2001) Direct diagnosis of human respiratory coronaviruses 229E and OC43 by the polymerase chain reaction. Journal of Virological Methods, 97, 59-66.
122. Vabret, A., Dina, J., Gouarin, S. et al. (2006) Detection of the new human coronavirus HKU1: a report of 6 cases. Clinical Infectious Diseases, 42, 634-39.
123. van Vliet, A.L., Smits, S.L., Rottier, P.J. and de Groot, R.J. (2002) Discontinuous and non-discontinuous subgenomic RNA transcription in a nidovirus. The EMBO Journal, 21, 6571-80.
124. Vijaykrishna, D., Smith, G.J., Zhang, J.X. et al. (2007) Evolutionary insights into the ecology of coronaviruses. Journal of Virology, 81, 4012-20.
125. Walsh, E.E., Falsey, A.R. and Hennessey, P.A. (1999) Respiratory syncytial and other virus infections in persons with chronic cardiopulmonary disease. American Journal of Respiratory and Critical Care Medicine, 160, 791-95.
126. Wang, D., Coscoy, L., Zylberberg, M. et al. (2002) Microarray-based detection and genotyping of viral pathogens. Proceedings of the National Academy of Sciences of the United States of America, 99, 15687-92.
127. Wang, D., Urisman, A., Liu, Y.T. et al. (2003) Viral discovery and sequence recovery using DNA microarrays. PLoS Biology, 1, E2.
128. Weiss, M. and Horzinek, M.C. (1987) The proposed family Toroviridae: agents of enteric infections. Brief review. Archives of Virology, 92, 1-15.
129. Wentworth, D.E. and Holmes, K.V. (2007) Coronavirus binding and entry, in Coronaviruses: Molecular and Cellular Biology (ed. V. Thiel), Caister Academic Press, Norfolk, VA, pp. 3-33.
130. Wong, C.K., Lam, C.W., Wu, A.K. et al. (2004) Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome. Clinical and Experimental Immunology, 136, 95-103.
131. Woo, P.C., Lau, S.K., Wong, B.H. et al. (2004) False-positive results in a recombinant severe acute respiratory syndrome-associated coronavirus (SARS-CoV) nucleocapsid enzyme-linked immunosorbent assay due to HCoV-OC43 and HCoV-229E rectified by Western blotting with recombinant SARS-CoV spike polypeptide. Journal of Clinical Microbiology, 42, 5885-88.
132. Woo, P.C., Lau, S.K., Chu, C.M. et al. (2005a) Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia. Journal of Virology, 79, 884-95.
133. Woo, P.C., Lau, S.K., Tsoi, H.W. et al. (2005b) Clinical and molecular epidemiological features of coronavirus HKU1-associated community-acquired pneumonia. The Journal of Infectious Diseases, 192, 1898-907.
134. Xu, R.H., He, J.F., Evans, M.R. et al. (2004) Epidemiologic clues to SARS origin in China. Emerging Infectious Diseases, 10, 1030-37.
135. Yi, C.E., Ba, L., Zhang, L. et al. (2005) Single amino acid substitutions in the severe acute respiratory syndrome coronavirus spike glycoprotein determine viral entry and immunogenicity of a major neutralizing domain. Journal of Virology, 79, 11638-46.
136. Yu, I.T., Li, Y., Wong, T.W. et al. (2004) Evidence of airborne transmission of the severe acute respiratory syndrome virus. The New England Journal of Medicine, 350, 1731-39.
137. Zhang, H., Zhou, G., Zhi, L. et al. (2005) Association between mannose-binding lectin gene polymorphisms and susceptibility to severe acute respiratory syndrome coronavirus infection. The Journal of Infectious Diseases, 192, 1355-61.
138. Zhu, Z., Chakraborti, S., He, Y. et al. (2007) Potent cross-reactive neutralization of SARS coronavirus isolates by human monoclonal antibodies. Proceedings of the National Academy of Sciences of the United States of America, 104, 12123-28.